CEN/TC 140
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 64279 | LVS EN ISO 22367:2020 | Medical laboratories - Application of risk management to medical laboratories (ISO 22367:2020) | Standarts spēkā |
| 70930 | EN ISO 18113-2:2024 | In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 2: In vitro diagnostic reagents for professional use (ISO 18113-2:2022) | Standarts spēkā |
| 75465 | LVS CEN/TS 17981-2:2023 | In vitro diagnostic Next Generation Sequencing (NGS) workflows - Part 2: Human RNA examination | Standarts spēkā |
| 70518 | LVS EN ISO 6717:2021 | In vitro diagnostic medical devices - Single-use containers for the collection of specimens from humans other than blood (ISO 6717:2021) | Standarts spēkā |
| 61694 | LVS EN ISO 20184-1:2019 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for frozen tissue - Part 1: Isolated RNA (ISO 20184-1:2018) | Standarts spēkā |
| 71064 | LVS EN ISO 20916:2024 | In vitro diagnostic medical devices - Clinical performance studies using specimens from human subjects - Good study practice (ISO 20916:2019) | Standarts spēkā |
| 68157 | EN ISO 15189:2022 | Medical laboratories - Requirements for quality and competence (ISO/DIS 15189:2021) | Standarts spēkā |
| 74322 | LVS CEN ISO/TS 5798:2023 | In vitro diagnostic test systems - Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods (ISO/TS 5798:2022) | Standarts spēkā |
| 74138 | CEN/TS 17981-1:2023 | In vitro diagnostic Next Generation Sequencing (NGS) workflows - Part 1: Human DNA examination | Standarts spēkā |
| 71064 | EN ISO 20916:2024 | In vitro diagnostic medical devices - Clinical performance studies using specimens from human subjects - Good study practice (ISO 20916:2019) | Standarts spēkā |
Displaying 71-80 of 276 results.